Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Indication-Specific Analgesics Slated For Mid-2001 Launch

This article was originally published in The Tan Sheet

Executive Summary

Perrigo plans to launch a Women's Menstrual Relief analgesic in April, comparable to McNeil Consumer Healthcare's Women's Tylenol, which debuted in October.
Advertisement

Related Content

Perrigo Boosts R&D Spending, Focuses On Quality Control
Perrigo Boosts R&D Spending, Focuses On Quality Control
Perrigo Boosts R&D Spending, Focuses On Quality Control
Perrigo New Product Program, Quality Control Back On Track In FY 2002
Women's Tylenol Marks McNeil Foray Into Menstrual Pain Category
Women's Tylenol Marks McNeil Foray Into Menstrual Pain Category
Whitehall Advil, Dimetapp Line Extensions Targeting Flu Symptoms
McNeil Motrin Migraine Pain, Aflexa Supplement National Ads Breaking Soon

Topics

Advertisement
UsernamePublicRestriction

Register

PS091914

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel